Julie Xing

Julie Xing

Director/Board Member at APTARGROUP, INC.

Net worth: 589 792 $ as of 31/05/2026

57 year
Health Technology
Process Industries
Commercial Services

Profile

Julie Xing is currently Executive Chairman at Mundipharma (China) Pharmaceutical Co., Ltd. since 2023 and Independent Director at AptarGroup, Inc. since 2023.
Former positions include Senior Director-Global New Product Planning at Eli Lilly & Co. from 2010 to 2019, VP, GM-Asia Pacific & Japan Operations at Panomics LLC, and Global Senior VP & President-Greater China at Envista Holdings Corp.
Education includes a doctorate from The Hong Kong University of Science & Technology.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
06/05/2026 5,091 ( 0.01% ) 589 792 $ 31/05/2026

Julie Xing active positions

CompaniesPositionStart
APTARGROUP, INC. Director/Board Member 01/03/2023
Chairman 01/03/2023

Former positions of Julie Xing

CompaniesPositionEnd
ELI LILLY AND COMPANY Corporate Officer/Principal 01/01/2019
AFFYMETRIX, INC. Corporate Officer/Principal -
Corporate Officer/Principal -
ENVISTA HOLDINGS CORPORATION Corporate Officer/Principal -
See the detail of Julie Xing's experience

Training of Julie Xing

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

61

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Process Industries

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!